Resources | Association for Accessible Medicines

Prescription Drug Safety: Education and Impact

Oct 30, 2018 | Chip Davis

Prescription Drug Safety: Education and Impact

Women in Health Policy Happy Hour October 2018

Oct 29, 2018 | Kristin Murphy

Women in Health Policy Gather at AAM

AAM Amicus Brief

Oct 17, 2018 | Jeff Francer

HELSINN v. TEVA

Supreme Court

Oct 17, 2018 | Rachel Schwartz

AAM Files Amicus Brief in Helsinn v Teva

Applauding Nomination of Dr. Scott Gottlieb to Lead the FDA

Oct 11, 2018 | Rachel Schwartz

AAM Statement on FDA Record Generic Approvals

FDA Approvals - Generic Drugs

Oct 10, 2018 | Chip Davis

Generic and Biosimilars Approvals Are Only Half the Story

New NAFTA - Proposed US-Mexico-Canada Agreement (USMCA)

Oct 9, 2018 | Jeff Francer

Op-Ed: The New NAFTA Could Thwart President's Promise to Lower Prescription Drug Costs

Direct Relief and AAM - Generic Prescriptions, AAM Member

Oct 4, 2018 | Rachel Schwartz

Prescription for Hope: AAM Members and Direct Relief

New NAFTA - Proposed US-Mexico-Canada Agreement (USMCA)

Oct 1, 2018 | Rachel Schwartz

AAM Opposes Barriers to Generic Drug and Biosimilar Access in Proposed US-Mexico-Canada Agreement (USMCA)

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Sep 26, 2018 | Erica Klinger

Preserve Patient Access in NAFTA 2.0

Sep 24, 2018 | Rachel Schwartz

Dana Mariani Joins AAM as Director, Policy

Sep 21, 2018 | Michael Brzica

$13.4 Billion a Year! Brand “Shenanigans” Are Costing Patients More Than Ever